← Back to All Stocks

NLS Pharmaceutics AG (NLSP) Analysis

Generated on: 2025-07-16 15:59:27 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 1,687,887 shares

Analysis Values

Current Price
$2.12
Predicted Price
$1.99
Expected Return
-5.37%
Confidence Score
0.82
RSI (14)
43.30
MACD
-0.01
Volume
25,738
Float Shares
1,687,887
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

NLSP

NLS Pharmaceutics AG
-5.37%
Price: $2.12
Confidence: 0.82
News
Low Float
Last updated: 2025-07-16 15:59:27

Technical Analysis

RSI: 43.30
MACD: -0.01
Technical Analysis Graph

Risk Analysis

Volatility
118.9%
Max Drawdown
-86.57%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
NLS Pharmaceutics and Kadimastem Advance Merger Plans with $500,000 Fundraising
TipRanks - 2025-01-09 13:28
NLS Pharmaceutics ( (NLSP) ) has issued an update. NLS Pharmaceutics and Kadimastem have announced the initial closing of a $500,000 fundraising effort, part of a larger $1 million initiative aimed at facilitating a proposed merger between the two companies. This merger seeks to create a Nasdaq-traded biotechnology company with advanced-stage product candidates, enhancing strategic positioning in the biotechnology sector and unlocking new opportunities for stakeholders. More about NLS Pharmaceut

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.